Mode
Text Size
Log in / Sign up
N/A N=130 Randomized Single-blind Supportive Care

Maternal Role in Oral Feed Establishment in Preterm Neonates

Preterm Birth · Tube Feeding · Swallowing Disorder · Maternal Care Patterns

Enrolled (actual)
130
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Transition Time to Full Oral Feeding — 10; 9 days

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
perioral sensory motor stimulation (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Fatima Memorial Hospital
Primary completion
May 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Transition Time to Full Oral Feeding
10; 9
PRIMARY
Improvement (Change) in Efficiency in Oral Feed Establishment
0; 0; 9; 12; 15; 16
PRIMARY
•Adverse Outcome Monitoring
31; 36; 14; 14; 12; 12
PRIMARY
•Adverse Events Monitoring
31; 36; 14; 14; 12; 12
SECONDARY
• Total Volume Taken During Each Feeding
2; 2; 3; 5; 4; 7
SECONDARY
• Volume Taken During the First 5 Min of Feeding (ml) VT5
2; 2; 3; 3; 3; 3
SECONDARY
•Rate of Transfer (RT) ml/Min
0.42; 0.42; 0.71; 0.70; 0.70; 0.70
SECONDARY
• Overall Transfer (OT Percent) Volume Taken/Total Volume Prescribed
21; 21; 35.7; 36; 43.8; 43.8
SECONDARY
• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume Prescribed
16; 16; 21; 21.6; 19.5; 23
SECONDARY
• Neonates Feeding With SSB Coordination
23; 22; 27; 33; 32; 33

Summary

Hypothesis Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will 1. Start taking oral feed at the same time as compared to control group 2. Take the same amount of milk at the commencement of oral feeding 3. Take milk with equal efficiency 4. Not face more adverse effects

Eligibility Criteria

Inclusion Criteria

  • All preterm of gestation age 28 to 34weeks
  • Haemodynamically stable
  • Established full Gavage feed
  • No respiratory distress
  • No need for respiratory support except LFNC
  • Do not receive any kind of analgesics

Exclusion Criteria

  • Syndromic babies /genetic disorders
  • Haemodynamically unstable babies including IVH (grade III & IV), hemodynamically significant PDA on treatment, NEC(stage III)
  • Major malformations
  • Cleft lip and palate
  • Anemia requiring blood transfusion
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05484726). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search